ABEO
Abeona Therapeutics Inc
5.40$
-0.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | – | – | – | 100.0% | – | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 25.5% | – | – | – | 16.2% | – | 25.0% | – | 52.3% | 40.9% | 36.7% | 43.4% | |
| – | -25.5% | – | – | – | -16.2% | – | 75.0% | – | 47.7% | 59.1% | 63.3% | 56.6% | |
| – | 261.3% | – | – | – | 188.1% | – | 1,485.8% | – | 123.8% | 109.6% | 44.1% | 99.9% | |
| – | 206.4% | – | – | – | 160.6% | – | 4,287.3% | – | 346.5% | 223.6% | 139.1% | 287.7% | |
| – | 442.2% | – | – | – | 332.4% | – | 5,773.0% | – | 470.4% | 323.3% | 183.3% | 384.3% | |
| – | -467.7% | – | – | – | -348.6% | – | -5,698.0% | – | -422.7% | -264.1% | -120.0% | -327.6% | |
| – | 3.9% | – | – | – | 22.6% | – | 239.3% | – | 16.3% | 9.5% | 6.1% | 13.0% | |
| – | -587.5% | – | – | – | -194.3% | – | 31,086.3% | – | -381.5% | -195.8% | -177.4% | -306.8% | |
| – | 24.0% | – | – | – | -14.2% | – | 3,878.0% | – | -4.0% | 0.0% | – | – | |
| – | -587.5% | – | – | – | -194.3% | – | 27,208.3% | – | -377.5% | -195.8% | -177.4% | -246.4% | |
| – | -558.1% | – | – | – | -155.5% | – | 31,517.5% | – | -345.0% | -176.3% | -165.2% | -279.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.